Hepatitis Awareness lecture held at JSMU (sponsored by Searle Biosciences Pvt, Ltd.)
Hepatitis Screening camp at Health Expo, 2017
Local Conference participation by SBPL
SEARLE INFUSIONS AND DISPOSABLES
MEDECO IV Cannulae
MEDECO Inject Insulin
MEDECO Auto Disable (RUP) Syringe (aproved supplier of WHO and UNICEF)
MEDECO Standard Syringe
Medeset Single use I.V Infusion set (basic and Y port)
SEARLE – NS (Macsol NS) IV Infusion (1000ml, 500ml, 100ml, 50ml, 20ml)
SEARLE – DS (Macsol DS) IV Infusion (1000ml, 500ml)
SEARLE – DS 1/2 (Macsol DS) IV Infusion (500ml)
SEARLE – 5% (Macsol 5%) IV Infusion (1000ml, 500ml, 100ml)
SEARLE – RL (Macsolate D) IV infusion (1000ml, 500ml)
SEARLE – PEADS (Macsol Peads) IV Infusion (500ml)
PROTiEX Surgical Gloves – Powdered (all ranges)
PROTiEX Surgical Gloves – Powder free (all ranges)
PROTiEX Examination Gloves (all ranges)
Exports are an entry route through which we have stayed true to our vision. Over the last few years,Global Business Division, aims at expanding Searle beyond the geographical boundaries of Pakistan, has successfully utilized the opportunity. Today, we are operating in South Asia, ASEAN and East Africa, planning to stretch our wings across North and West Africa.
Afghanistan which literally means Land of Afghans is a mountainous, land-locked country located in south-central Asia. The region has a history and culture that dates back over 5,000 years, due to long standing civil war the country infrastructure is seriously damaged and no industry has flourished the country mainly dependent on imports all kinds of goods and services including Pharmaceuticals to fulfill needs of the people.
The Searle Company Limited commenced marketing and sales operations in Afghanistan decades ago. The company operates in Afghanistan with well-trained teams dedicated to provide quality medicine to the people of Afghanistan. We are among the top players of the pharmaceutical industry of Afghanistan having quality products among major therapeutics areas including Cardio metabolic, gastroenterology, antibiotics, Pain management, psychiatry, rheumatology and others.
Gardens of the Babur
Annual Sales Conference 2016
Cambodia, a culturally rich South East Asian country has a fast-emerging economy with youngest population in the region. Country’s pharmaceutical market size is approximately US$270 million with a CAGR of 12%. Cambodia’s pharmaceutical market is heavily dependent upon imports from South Asia & ASEAN region.
Cambodia is among the newer operations in Searle’s Global Business Division. Searle’s Cambodia operation started in 2011 on a trading model with a strategic shift to marketing model in 2015. With continuous expansion & growth, Searle has now established a strong foothold in Cambodia pharma market with an energetic team & a highly diversified product line in CardioMetabolic, Gastroenterology, Psychiatry, Hepatology, ENT, Pain Management & other segments.
Annual Sales Conference 2016
Team Training Session
Kenya is most developed country in East African region, famous for its wild life safari and Tea, Coffee plantations. Kenya pharmaceutical market size reached up to $720 to $750 million. Kenya is Now become most advance & regulated country for pharmaceutical sector in East Africa.
Kenya Major Pharmaceutical volumes are based on imports. Exports come from Pakistan, China, India Turkey & research Originated Companies.Kenya’s Capital city Nairobi is most developed city in this region and is the reason whypharmaceutical companiesare operating their regional offices in Nairobi.
Searle started its Kenya operations in 1998 and started exporting in 2001. In January 2017, Searle shifted to Marketing Model replacing old trading concept.Currently Searle’s Kenya working product portfolios are cardiovascular, Paediatrics & Gastroenterology.
Myanmar, being the largest country in mainland Southeast Asia has a population of 57 million. It has a pharmaceutical market size of approximately US$409 million with a CAGR of 13-14%. Myanmar’s pharmaceutical market is mainly dependent upon imports from South Asia & ASEAN region.
Searle’s Myanmar operation started back in 2000 on a trading model with transition to marketing model in 2015. Aimed at continued growth and expansion in various therapeutic segments, Searle Myanmar has an established portfolio in Anti-infectives, Psychiatry, Cardio metabolic, Gastroenterology, Pain Management, ENT and Respiratory segments.
Myanmar Team – ASC 2016
Yangon’s Famous Shwedagon Pagoda
Myanmar National Flag
Philippines is the 3rd largest economy in the ASEAN and one of the emerging markets and is the sixth richest in Southeast Asia by GDP per capita values. With the population of 105 Million, Philippines ranks 13th in the list of countries by population. The size of Pharmaceutical market is 3.23 Billion USD which is expected to reach 4.1 Billion USD by the year 2020.
Searle started its operations in Philippines in 2011 with the trading model. Keeping in view the strategic importance of the highly established Pharmaceutical and Healthcare market, Searle has established its legal entity with the name of Searle Pharmaceuticals Inc. which will play an imperative role in establishing Searle’s own marketing setup in future.
Sri Lanka is an island located in South of India with diverse landscapes range from rainforest and arid plains to highlands and sandy beaches. It has a population size of 21Million approximately. Pharmaceutical Industry is mainly relying on imports and the market size of US$350Million with a single digit growth.
Sigiriya, a first century BC monastery which was later converted into a pleasure garden and a fortress
Searle started its operation in 1993 and with the passage of time, it has established its presence among the leading the Pharmaceutical Companies with its quality products and the large fleet of people who are the assets of the company. Now, Sri Lanka is one of the strategic and sizeable pharmaceutical contributing countries for Searle and the operation will expand and grow by leaps and bounds in coming years.
Vietnam is a upcoming country with population of 95 Million in Southeast Asia on the South China Sea known for its beaches, rivers, Buddhist pagodas and bustling cities. Vietnam may be the fastest-growing of the world’s emerging economies by 2025, with a potential growth rate of almost 10% per annum in real dollar terms.
Vietnam health sector is highly regularized & following international guide lines by its regulatory authorities to provide quality medicines and heatlhcare services to its people. Vietnam pharmaceutical market size reached up to $ 5.1 Billion with projected Growth rate of 16%.
Vietnam is one of the major contributing country in Searle Pharmaceutical Exports. Searle started its operations in 2002 with setting up its representative office in Ho Chi Minh City.
Currently Searle Vietnam has an established product portfolio with leading products in cardiovascular segment.
Vietnam National Flag
Souvenir of Vietnam, miniature conical hats
Halong bay, Vietnam
SAFETY OF PRODUCTS
Humans vary in their biological reactions to medicinal products. This is why not all adverse reactions (side effects) associated with the use of medicinal products can be detected during clinical development, not even by the most comprehensive clinical trials.
Searle as a responsible organization focused on healthcare products safety. If you experience any unanticipated side effects, kindly report to
Please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:
- Name of the Searle medical product:
Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Please specify what are you using the product for. Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the adverse event.
- The adverse event associated with the drug:
Description of details of the adverse event(s) and any additional product or procedure to treat the adverse event. Name of healthcare provider who provided treatment and contact information.
- Your name (optional) and occupation:
Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Searle Pharmacovigilance unit may contact you for further information about the adverse event. If you do not wish to be contacted, you should indicate this in your email. Please specify your occupation.
- Information about the person who experienced the adverse event:
Any other medical conditions currently ongoing. Other medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).